E
Eileen de Feo
Researcher at Illumina
Publications - 8
Citations - 925
Eileen de Feo is an academic researcher from Illumina. The author has contributed to research in topics: Prenatal diagnosis & Trisomy. The author has an hindex of 5, co-authored 7 publications receiving 724 citations.
Papers
More filters
Journal ArticleDOI
Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood
Amy J. Sehnert,Brian Kent Rhees,David Comstock,Eileen de Feo,Gabrielle Heilek,John P. Burke,Richard P. Rava +6 more
TL;DR: Massively parallel sequencing is capable of detecting multiple fetal chromosomal abnormalities from maternal plasma when an optimized algorithm is used.
Journal ArticleDOI
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States.
Nicole L. Washington,Karthik Gangavarapu,Mark Zeller,Alexandre Bolze,Elizabeth T. Cirulli,Kelly M. Schiabor Barrett,Brendan B. Larsen,Catelyn Anderson,Simon R. White,Tyler Cassens,Sharoni Jacobs,Geraint Levan,Jason Nguyen,Jimmy M. Ramirez,Charlotte Rivera-Garcia,Efren Sandoval,Xueqing Wang,David T.W. Wong,Emily Spencer,Refugio Robles-Sikisaka,Ezra Kurzban,Laura D. Hughes,Xianding Deng,Candace Wang,Venice Servellita,Holly Valentine,Peter De Hoff,Phoebe Seaver,Shashank Sathe,Kimberly Gietzen,Brad Sickler,Jay Antico,Kelly Hoon,Jingtao Liu,Aaron Harding,Omid Bakhtar,Tracy Basler,Brett Austin,Duncan MacCannell,Magnus Isaksson,Phillip G. Febbo,David M. Becker,Marc Laurent,Eric McDonald,Gene W. Yeo,Rob Knight,Louise C. Laurent,Eileen de Feo,Michael Worobey,Charles Y. Chiu,Marc A. Suchard,James T. Lu,William E. Lee,Kristian G. Andersen +53 more
TL;DR: In this paper, the authors investigated the prevalence and dynamics of B.1.7 in the United States (US), tracking it back to its early emergence using S gene target failure (SGTF) and SARS-CoV-2 genomic sequencing.
Journal ArticleDOI
Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples
TL;DR: The aim of this study is to report the experience of noninvasive prenatal DNA testing using massively parallel sequencing in an accredited clinical laboratory.
Posted ContentDOI
Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
Nicole L. Washington,Karthik Gangavarapu,Mark Zeller,Alexandre Bolze,Elizabeth T. Cirulli,Kelly M. Schiabor Barrett,Brendan B. Larsen,Catelyn Anderson,Simon R. White,Tyler Cassens,Sharoni Jacobs,Geraint Levan,Jason Nguyen,Jimmy M. Ramirez,Charlotte Rivera-Garcia,Efren Sandoval,Xueqing Wang,David T.W. Wong,Emily Spencer,Refugio Robles-Sikisaka,Ezra Kurzban,Laura D. Hughes,Xianding Deng,Candace Wang,Venice Servellita,Holly Valentine,Peter De Hoff,Phoebe Seaver,Shashank Sathe,Kimberly Gietzen,Brad Sickler,Jay Antico,Kelly Hoon,Jingtao Liu,Aaron Harding,Omid Bakhtar,Tracy Basler,Brett Austin,Magnus Isaksson,Phil Febbo,David M. Becker,Marc Laurent,Eric McDonald,Gene W. Yeo,Rob Knight,Louise C. Laurent,Eileen de Feo,Michael Worobey,Charles Y. Chiu,Marc A. Suchard,James T. Lu,William E. Lee,Kristian G. Andersen,Kristian G. Andersen +53 more
TL;DR: For example, Washington et al. as discussed by the authors investigated the prevalence and growth dynamics of the SARS-CoV-2 variant in the United States (U.S.), tracking it back to its early emergence and onward local transmission.
Journal ArticleDOI
Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases.
Patricia A. Taneja,Holly L. Snyder,Eileen de Feo,Kristina M. Kruglyak,Meredith Halks-Miller,Kirsten J. Curnow,Sucheta Bhatt +6 more
TL;DR: The primary goal of this study was to provide clinically relevant information for appropriate patient counseling.